Jerusalem (August 21)
On August 21 2019, The Cannabis Society flew overseas and hosted our first cannabis industry event in Jerusalem, Israel.
This innovative and exciting conference included leading researchers, industry experts, investors and licensed producers in the domestic market.
After the opening remarks by our CEO, Bill Hennessey, Eyal Mishori Head of Business Development for top Israeli LP Breath of Life discussed their clinical pipeline and unique facility design as a global innovator in medical cannabis technologies. The first panel commenced and consisted of 4 companies focused on IP and the incredible R&D potential of Israel. The panel was moderated by Dr. Inbar Maymon Pomeranchik, PhD, Founder of Biodiligence. The R&D panelists included Abraham Dreazan, CEO of Nextage; Yotam Hod, CEO of Asana Group; Dr. Hinanit Koltai, lead researcher at the Volcani Institute; and Nir Peles, founder of Cannasure. The panelists focused on the importance of true pharma formulations and the necessity of clinical trial investment to shape the medical cannabis industry.
Our second panel comprised of leading investors in the global space. Israel has a significant VC community and lead investors such as Ofer Spottheim of Canndu Investments, Ronnie Jaegerman, Director of Aloni Haft Investment Banking; David Hess, Director of Tress Capital; and Shiri Eden, CEO of Nishot provided deep insight into investment opportunities and the landscape of the Israeli ecosystem. The Tel Aviv Stock Exchange seen bullish activity of companies listing and share volume trades.
After an exciting networking session and lunch hosted by venue sponsor Biohouse, a biotech co-working space attached to Hadassah Hospital. Top CEOs debated the promising future and obstacles Israeli companies face when competing in the global markets. I-can CEO, Saul Kaye; Omer Zerahia, Managing Director of Canndoc; Irai Rogel, Head of Business Development for Bazelet; and Golan Bitton, CEO of Univo provided their own perspectives and insights into the Israeli strategic position. While all these executives agree Israel's greatest asset is the R&D potential their strategies for market execution could not be more different from each other.
The last panel of this first to market event displayed unique startups with technologies varying between agricultural technologies, consumer brands, medical formulations, and cannabis in food tech. These companies emphasized the diverse capabilities of the cannabis plant and its ability to open new markets for consumer branding. Innocan, Cannibble, Roots Sustainable Agriculture Technologies, and Cannavate emphasized the saying Israel, the startup nation.